Stock Comparison

ARGX vs ARWR

argenx NV ADR and Arrowhead Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

ARWR

Arrowhead Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$53.23B

$12.00B

P/E (TTM)

32.7

—

Forward P/E

30.4

107.7

Price/Sales

10.0

17.9

Price/Book

6.4

25.8

EV/EBITDA

27.6

27.0

Dividend Yield

—

Profitability

Net Margin

30.44%

-47.79%

Operating Margin

27.34%

-33.82%

Return on Equity

23.60%

-55.20%

Return on Assets

11.60%

-8.10%

Growth (YoY)

Revenue Growth

59.30%

171.00%

Earnings Growth

95.20%

9.80%

Price & Risk

Beta

-0.0

1.3

52-Week High

$939.68

$89.59

52-Week Low

$652.43

$18.78

Analyst Target

$1,085.78

$110.18

Compare ARGX and ARWR your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.